Shares in Harvard Bioscience fell 8.8 percent for the five-day trading period ended Tuesday, leading all decliners in the BCW Index. Last week, Harvard Bio reported a fourth-quarter loss as investors and customers continue to wait for the sale of the firm's capital equipment business (see briefs). Bio-Rad's shares posted the biggest gain, rising 4 percent for the week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.